AEterna Zentaris: Stocks trading at Less Than Cash Value on TSX (AEZS)
AEterna Zentaris is among the group of Toronto Stock Exchange companies currently trading at less than cash value. This means companies whose current share price is less than the cash per share on their balance sheet or stocks with more cash than market cap.
This report is generated monthly. It also shows the value of cash net debt per share to show how much cash per share would be left if the debt was paid off. Stocks in this category are held primarily for speculation.
Companies can have more cash per share than the actual share price for a number of reasons including that they just raised capital, are in industries that experience high burn rates and will eat through the cash quickly or there is a lot of uncertainty about the future of the company. Companies earning a positive net income will have a price-to-earnings, or P/E, ratio greater than zero and are worth exploring in more detail.
| Symbol | Name | Close Price | Shares Outstanding | P/E | P/B | Cash per Share | Net Cash per Share |
|---|---|---|---|---|---|---|---|
| BBU.UN | Brookfield Bus Partners | 27.18 | 74558912 | 204.5436 | 1.0919 | 39.74 | -576.05 |
| CF | Canaccord Genuity Gr | 8 | 99381623 | 10.9811 | 0.9974 | 8.99 | -0.56 |
| TSAT | Telesat | 13.38 | 13599011 | 1.0678 | 0.2736 | 130.53 | -113.09 |
| TRZ | Transat A.T. | 3.62 | 38595923 | 4.1465 | 42.0673 | 11.29 | -37.7 |
| BRMI | Boat Rocker Media | 1.17 | 56357072 | 0.319 | 1.52 | -2.1 | |
| AEZS | AEterna Zentaris | 2.57 | 4855876 | 0.3575 | 7.98 | 7.94 |
All data provided as of December 22, 2023.
More about AEterna Zentaris
AEterna Zentaris Inc is a biopharmaceutical company commercializing & developing therapeutics & diagnostic tests. The company's product, Macrilen (macimorelin), is the oral test indicated for the diagnosis of adult growth hormone deficiency (GHD). Macrilen is marketed in the U.S. through a license agreement with Novo Nordisk & the company receives royalties on sales. Aeterna owns all rights to macimorelin outside of the U.S. & Canada.
AEterna Zentaris is listed under AEZS on the Toronto Stock Exchange.
Artificial intelligence at Report on Business
Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.
